News & Press
Munich, March 2015 – As of now, the European Cyberknife Center Munich-Grosshadern (ECZM) in cooperation with the Department of Urology, Klinikum Grosshadern, University of Munich, treats low and intermediate risk prostate cancer with Cyberknife. This modern technology kills prostate cancer effectively with little side effects. The Cyberknife technology is based on an integration of an image guided system and a robotic radiation delivery unit. Due to its high end technology, Cyberknife tracks the tumor with submillimeter precision while protecting surrounding healthy tissue and organs. The ECZM has an extensive experience in treating patients with benign or malignant tumors in over 8,000 cases overall. A Cyberknife treatment may be an effective alternative to conventional therapies for prostate cancer.